SAN DIEGO, April 20, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Illumina, Inc. (NASDAQ: ILMN) and certain of its officers. Illumina provides sequencing and array-based solutions for genetic analysis.
Specifically, Johnson & Weaver's investigation seeks to determine whether certain statements regarding Illumina's business and prospects were false and misleading when made. On April 18, 2016, Illumina reported preliminary first-quarter revenue well below expectations. The firm said it expects revenues of $572 million, well below the $596 million originally forecast, citing weak device sales. Illumina also stated that it sees 2016 revenue growth of 12 percent; it's slowest in four years. On the news, Illumina shares plummeted more than 23% on April 19, 2016.
If you are an Illumina shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (firstname.lastname@example.org) at 619-814-4471. If you email, please include your phone number.
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
SOURCE Johnson & Weaver, LLP